Effect of taurine on vascular dysfunction in an in vitro ischemia-reperfusion model of rat thoracic aorta
The primary objective of this study was to evaluate the protective effect of taurine on endothelial dysfunction in a vascular ischemia-reperfusion (IR) model. Thoracic aortas of 9 male Sprague-Dawley rats (350-500 g) were cut into rings and randomized into control (n = 7), IR (n = 8), IR + taurine 1...
Saved in:
Published in: | General thoracic and cardiovascular surgery |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Japan
30-09-2024
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The primary objective of this study was to evaluate the protective effect of taurine on endothelial dysfunction in a vascular ischemia-reperfusion (IR) model.
Thoracic aortas of 9 male Sprague-Dawley rats (350-500 g) were cut into rings and randomized into control (n = 7), IR (n = 8), IR + taurine 1 mM (n = 7), IR + taurine 10 mM (n = 8), IR + taurine 30 mM (n = 8), and IR + taurine 100 mM (n = 5) groups. Aortic rings in the IR group were stored in 0.9% saline at 4 °C for 24 h, placed in Krebs-Henseleit solution gassed with 95%O
+ 5%CO
at 37 °C, and exposed to sodium hypochlorite (200 μM) for 30 min. Responses to KCl (80 mM), phenylephrine (10
-10
M), acetylcholine (10
-10
M), and sodium nitroprusside (SNP, 10
-10
M) were recorded. E
(maximum response) and pD
(negative logarithm of concentration producing half-maximum response) were calculated.
IR decreased KCl contraction (control 1047 ± 176 mg, IR 682 ± 128 mg, p = 0.0007), which was reversed by 30 and 100 mM taurine (960 ± 313 mg, p = 0.02 and 1066 ± 488 mg, p = 0.02, respectively). IR impaired phenylephrine, acetylcholine, and SNP responses (p < 0.0001). Taurine did not affect IR-impaired phenylephrine contractions. IR decreased both pD
(control, 7.1 ± 0.1; IR, 6.0 ± 0.2; p < 0.01) and E
(control, 83.5 ± 2.7%; IR, 26.8 ± 2.5%; p < 0.0001) of acetylcholine relaxation, both of which were reversed by 100 mM taurine (pD
7.2 ± 0.1; p < 0.001; E
45.4 ± 2.6%; p < 0.0001). For SNP relaxation, IR decreased pD
(control 8.2 ± 0.1, IR 7.7 ± 0.1, p < 0.01), which was reversed by 100 mM taurine (8.5 ± 0.1, p < 0.0001).
Taurine protects endothelial function after IR injury. Further studies should explore the mechanism of this effect and the potential of adding taurine to vascular graft storage solutions. |
---|---|
AbstractList | The primary objective of this study was to evaluate the protective effect of taurine on endothelial dysfunction in a vascular ischemia-reperfusion (IR) model.
Thoracic aortas of 9 male Sprague-Dawley rats (350-500 g) were cut into rings and randomized into control (n = 7), IR (n = 8), IR + taurine 1 mM (n = 7), IR + taurine 10 mM (n = 8), IR + taurine 30 mM (n = 8), and IR + taurine 100 mM (n = 5) groups. Aortic rings in the IR group were stored in 0.9% saline at 4 °C for 24 h, placed in Krebs-Henseleit solution gassed with 95%O
+ 5%CO
at 37 °C, and exposed to sodium hypochlorite (200 μM) for 30 min. Responses to KCl (80 mM), phenylephrine (10
-10
M), acetylcholine (10
-10
M), and sodium nitroprusside (SNP, 10
-10
M) were recorded. E
(maximum response) and pD
(negative logarithm of concentration producing half-maximum response) were calculated.
IR decreased KCl contraction (control 1047 ± 176 mg, IR 682 ± 128 mg, p = 0.0007), which was reversed by 30 and 100 mM taurine (960 ± 313 mg, p = 0.02 and 1066 ± 488 mg, p = 0.02, respectively). IR impaired phenylephrine, acetylcholine, and SNP responses (p < 0.0001). Taurine did not affect IR-impaired phenylephrine contractions. IR decreased both pD
(control, 7.1 ± 0.1; IR, 6.0 ± 0.2; p < 0.01) and E
(control, 83.5 ± 2.7%; IR, 26.8 ± 2.5%; p < 0.0001) of acetylcholine relaxation, both of which were reversed by 100 mM taurine (pD
7.2 ± 0.1; p < 0.001; E
45.4 ± 2.6%; p < 0.0001). For SNP relaxation, IR decreased pD
(control 8.2 ± 0.1, IR 7.7 ± 0.1, p < 0.01), which was reversed by 100 mM taurine (8.5 ± 0.1, p < 0.0001).
Taurine protects endothelial function after IR injury. Further studies should explore the mechanism of this effect and the potential of adding taurine to vascular graft storage solutions. The primary objective of this study was to evaluate the protective effect of taurine on endothelial dysfunction in a vascular ischemia-reperfusion (IR) model.OBJECTIVEThe primary objective of this study was to evaluate the protective effect of taurine on endothelial dysfunction in a vascular ischemia-reperfusion (IR) model.Thoracic aortas of 9 male Sprague-Dawley rats (350-500 g) were cut into rings and randomized into control (n = 7), IR (n = 8), IR + taurine 1 mM (n = 7), IR + taurine 10 mM (n = 8), IR + taurine 30 mM (n = 8), and IR + taurine 100 mM (n = 5) groups. Aortic rings in the IR group were stored in 0.9% saline at 4 °C for 24 h, placed in Krebs-Henseleit solution gassed with 95%O2 + 5%CO2 at 37 °C, and exposed to sodium hypochlorite (200 μM) for 30 min. Responses to KCl (80 mM), phenylephrine (10-10-10-4 M), acetylcholine (10-10-10-4 M), and sodium nitroprusside (SNP, 10-11-10-5 M) were recorded. Emax (maximum response) and pD2 (negative logarithm of concentration producing half-maximum response) were calculated.METHODSThoracic aortas of 9 male Sprague-Dawley rats (350-500 g) were cut into rings and randomized into control (n = 7), IR (n = 8), IR + taurine 1 mM (n = 7), IR + taurine 10 mM (n = 8), IR + taurine 30 mM (n = 8), and IR + taurine 100 mM (n = 5) groups. Aortic rings in the IR group were stored in 0.9% saline at 4 °C for 24 h, placed in Krebs-Henseleit solution gassed with 95%O2 + 5%CO2 at 37 °C, and exposed to sodium hypochlorite (200 μM) for 30 min. Responses to KCl (80 mM), phenylephrine (10-10-10-4 M), acetylcholine (10-10-10-4 M), and sodium nitroprusside (SNP, 10-11-10-5 M) were recorded. Emax (maximum response) and pD2 (negative logarithm of concentration producing half-maximum response) were calculated.IR decreased KCl contraction (control 1047 ± 176 mg, IR 682 ± 128 mg, p = 0.0007), which was reversed by 30 and 100 mM taurine (960 ± 313 mg, p = 0.02 and 1066 ± 488 mg, p = 0.02, respectively). IR impaired phenylephrine, acetylcholine, and SNP responses (p < 0.0001). Taurine did not affect IR-impaired phenylephrine contractions. IR decreased both pD2 (control, 7.1 ± 0.1; IR, 6.0 ± 0.2; p < 0.01) and Emax (control, 83.5 ± 2.7%; IR, 26.8 ± 2.5%; p < 0.0001) of acetylcholine relaxation, both of which were reversed by 100 mM taurine (pD2, 7.2 ± 0.1; p < 0.001; Emax, 45.4 ± 2.6%; p < 0.0001). For SNP relaxation, IR decreased pD2 (control 8.2 ± 0.1, IR 7.7 ± 0.1, p < 0.01), which was reversed by 100 mM taurine (8.5 ± 0.1, p < 0.0001).RESULTSIR decreased KCl contraction (control 1047 ± 176 mg, IR 682 ± 128 mg, p = 0.0007), which was reversed by 30 and 100 mM taurine (960 ± 313 mg, p = 0.02 and 1066 ± 488 mg, p = 0.02, respectively). IR impaired phenylephrine, acetylcholine, and SNP responses (p < 0.0001). Taurine did not affect IR-impaired phenylephrine contractions. IR decreased both pD2 (control, 7.1 ± 0.1; IR, 6.0 ± 0.2; p < 0.01) and Emax (control, 83.5 ± 2.7%; IR, 26.8 ± 2.5%; p < 0.0001) of acetylcholine relaxation, both of which were reversed by 100 mM taurine (pD2, 7.2 ± 0.1; p < 0.001; Emax, 45.4 ± 2.6%; p < 0.0001). For SNP relaxation, IR decreased pD2 (control 8.2 ± 0.1, IR 7.7 ± 0.1, p < 0.01), which was reversed by 100 mM taurine (8.5 ± 0.1, p < 0.0001).Taurine protects endothelial function after IR injury. Further studies should explore the mechanism of this effect and the potential of adding taurine to vascular graft storage solutions.CONCLUSIONTaurine protects endothelial function after IR injury. Further studies should explore the mechanism of this effect and the potential of adding taurine to vascular graft storage solutions. |
Author | Efe, Oğuzhan Ekin Zeynalova, Nargiz Teimoori, Ariyan Demirtaş, Elif Orhan, Halit Güner Emre Aydıngöz, Selda |
Author_xml | – sequence: 1 givenname: Ariyan surname: Teimoori fullname: Teimoori, Ariyan organization: Department of Medical Pharmacology, Başkent University Faculty of Medicine, Ankara, Turkey – sequence: 2 givenname: Halit Güner surname: Orhan fullname: Orhan, Halit Güner organization: Department of Medical Pharmacology, Başkent University Faculty of Medicine, Ankara, Turkey – sequence: 3 givenname: Elif surname: Demirtaş fullname: Demirtaş, Elif organization: Department of Medical Pharmacology, Başkent University Faculty of Medicine, Ankara, Turkey – sequence: 4 givenname: Nargiz surname: Zeynalova fullname: Zeynalova, Nargiz organization: Department of Medical Pharmacology, Başkent University Faculty of Medicine, Ankara, Turkey – sequence: 5 givenname: Oğuzhan Ekin surname: Efe fullname: Efe, Oğuzhan Ekin organization: Department of Medical Pharmacology, Başkent University Faculty of Medicine, Ankara, Turkey – sequence: 6 givenname: Selda orcidid: 0000-0001-7823-7620 surname: Emre Aydıngöz fullname: Emre Aydıngöz, Selda email: seldaemre71@yahoo.com organization: Department of Medical Pharmacology, Başkent University Faculty of Medicine, Ankara, Turkey. seldaemre71@yahoo.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39349917$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kEtLxDAUhYMojq8_4EKydFNNmjaPpQy-QHCj63AnvcFI24xJKsy_t-OMLu6DyzmHy3dKDsc4IiGXnN1wxtRt5lw1umJ1MxfTpjIH5IRrKSqpuDj831m7IKc5fzLWSs3bY7IQRjTGcHVCwr336AqNnhaYUhiRxpF-Q3ZTD4l2m-yn0ZUwH8NI4bd_h5IiDdl94BCgSrjG5Ke81Qyxw34blqDQ8hETuOAoxFTgnBx56DNe7OcZeX-4f1s-VS-vj8_Lu5fKcd2UymgnndLK1KoBjbVrJMO6WymlPIMGtfSuRpDgO7lqvWFspTh3TBjVILYgzsj1Lned4teEudhhfhX7HkaMU7aCcy7FDK6epfVO6lLMOaG36xQGSBvLmd0itjvEdkZsfxFbM5uu9vnTasDu3_LHVPwAehZ6PA |
Cites_doi | 10.1016/j.resuscitation.2006.12.011 10.1097/SLA.0b013e318288c38d 10.1161/01.ATV.0000143388.20994.fa 10.1007/978-0-387-75681-3_4 10.1016/j.jff.2022.105187 10.1371/journal.pone.0105851 10.1080/10520295.2017.1367033 10.3758/BF03193146 10.4196/kjpp.2017.21.6.617 10.1007/s007260070011 10.1007/s00394-018-1616-2 10.1007/s00726-012-1378-8 10.1111/j.1476-5381.1994.tb13092.x 10.2174/1573406411666150928112420 10.21037/jtd-23-636 10.1016/j.lfs.2007.11.012 10.1038/s41569-019-0249-3 10.1093/jn/136.6.1636S 10.1016/j.etp.2004.08.004 10.1002/jcb.1271 10.1139/y03-088 10.1007/s00726-022-03198-6 10.3390/ph14101028 10.1139/y90-016 10.1111/j.1472-8206.1991.tb00716.x 10.1161/STROKEAHA.114.005888 10.1007/s10557-008-6124-9 10.1161/CIRCULATIONAHA.120.052163 10.1155/2022/7019088 10.3390/molecules26164913 10.1161/HYPERTENSIONAHA.115.06624 10.1007/s00210-019-01727-x |
ContentType | Journal Article |
Copyright | 2024. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery. |
Copyright_xml | – notice: 2024. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1007/s11748-024-02089-9 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1863-6713 |
ExternalDocumentID | 10_1007_s11748_024_02089_9 39349917 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Baskent Üniversitesi grantid: DA22/33 |
GroupedDBID | --- -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29H 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACZOJ ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD B-. BA0 BGNMA CS3 CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI ESBYG F5P FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 HF~ HG5 HG6 HLICF HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZQ I~X I~Z J-C J0Z JBSCW JMI JZLTJ KDC KOV KPH LLZTM M4Y MA- MOJWN NPM NPVJJ NQJWS NU0 O93 O9I O9J OAM P9S PF0 PT4 QOR QOS R89 R9I ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WJK WK8 YLTOR Z45 Z7U Z82 Z83 Z87 ZMTXR ZOVNA ~A9 AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c184t-98c6c7879274a8e2c460e2db777f0a4e86fc2ea6afd6b5f900b711c03974ee5a3 |
ISSN | 1863-6705 1863-6713 |
IngestDate | Sat Oct 26 02:24:53 EDT 2024 Fri Nov 22 01:48:29 EST 2024 Sat Nov 02 12:29:32 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Taurine Ischemia‒reperfusion Rat Organ bath In vitro |
Language | English |
License | 2024. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c184t-98c6c7879274a8e2c460e2db777f0a4e86fc2ea6afd6b5f900b711c03974ee5a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7823-7620 |
PMID | 39349917 |
PQID | 3111637482 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_3111637482 crossref_primary_10_1007_s11748_024_02089_9 pubmed_primary_39349917 |
PublicationCentury | 2000 |
PublicationDate | 2024-Sep-30 2024-09-30 20240930 |
PublicationDateYYYYMMDD | 2024-09-30 |
PublicationDate_xml | – month: 09 year: 2024 text: 2024-Sep-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | General thoracic and cardiovascular surgery |
PublicationTitleAlternate | Gen Thorac Cardiovasc Surg |
PublicationYear | 2024 |
References | HG Orhan (2089_CR15) 2023; 20 GC Bompotis (2089_CR34) 2016; 12 MT Ristori (2089_CR36) 1991; 5 S Nishida (2089_CR31) 2019; 643 E Caliskan (2089_CR2) 2020; 17 S Korkmaz-Icöz (2089_CR5) 2021; 14 W Abebe (2089_CR26) 2003; 81 MJ Cipolla (2089_CR21) 2014; 45 CJ Jong (2089_CR35) 2021; 26 N Krezdorn (2089_CR4) 2017; 2 SW Schaffer (2089_CR10) 2014; 46 R Stocker (2089_CR20) 2004; 24 T Ueno (2089_CR17) 2007; 73 W Abebe (2089_CR25) 2000; 19 BR Erdogan (2089_CR19) 2020; 393 O Yildiz (2089_CR14) 2022; 54 B Ballikaya (2089_CR6) 2022; 14 J Lopez-Menendez (2089_CR9) 2023; 15 JT Brosnan (2089_CR11) 2006; 136 W Xue (2089_CR37) 2008; 22 OL Woodman (2089_CR33) 1994; 112 AR Maia (2089_CR28) 2014; 9 W Abebe (2089_CR12) 2011; 1 C González (2089_CR32) 1990; 68 RE Harskamp (2089_CR3) 2013; 257 J Hanna (2089_CR16) 2004; 56 K Karabacak (2089_CR13) 2015; 19 KG Ulusoy (2089_CR30) 2017; 21 Q Sun (2089_CR38) 2016; 67 I Xenogiannis (2089_CR1) 2021; 144 S Korkmaz-Icöz (2089_CR7) 2022; 95 TM Seasholtz (2089_CR22) 1985; 2001 F Faul (2089_CR23) 2007; 39 N Berna (2089_CR24) 2001; 84 VF Leão (2089_CR29) 2019; 58 S Korkmaz-Icöz (2089_CR8) 2022; 2022 Z Cavdar (2089_CR18) 2017; 92 W Abebe (2089_CR27) 2008; 82 |
References_xml | – volume: 73 start-page: 287 year: 2007 ident: 2089_CR17 publication-title: Resuscitation doi: 10.1016/j.resuscitation.2006.12.011 contributor: fullname: T Ueno – volume: 2 start-page: 171 year: 2017 ident: 2089_CR4 publication-title: Innov Surg Sci contributor: fullname: N Krezdorn – volume: 257 start-page: 824 year: 2013 ident: 2089_CR3 publication-title: Ann Surg doi: 10.1097/SLA.0b013e318288c38d contributor: fullname: RE Harskamp – volume: 20 start-page: 173 year: 2023 ident: 2089_CR15 publication-title: Kardiochir Torakochirurgia Pol contributor: fullname: HG Orhan – volume: 24 start-page: 2028 year: 2004 ident: 2089_CR20 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000143388.20994.fa contributor: fullname: R Stocker – volume: 643 start-page: 37 year: 2019 ident: 2089_CR31 publication-title: Adv Exp Med Biol doi: 10.1007/978-0-387-75681-3_4 contributor: fullname: S Nishida – volume: 95 year: 2022 ident: 2089_CR7 publication-title: J Func Foods doi: 10.1016/j.jff.2022.105187 contributor: fullname: S Korkmaz-Icöz – volume: 9 year: 2014 ident: 2089_CR28 publication-title: PLoS ONE doi: 10.1371/journal.pone.0105851 contributor: fullname: AR Maia – volume: 92 start-page: 524 year: 2017 ident: 2089_CR18 publication-title: Biotech Histochem doi: 10.1080/10520295.2017.1367033 contributor: fullname: Z Cavdar – volume: 1 start-page: 293 year: 2011 ident: 2089_CR12 publication-title: Am J Cardiovasc Dis contributor: fullname: W Abebe – volume: 39 start-page: 175 year: 2007 ident: 2089_CR23 publication-title: Behav Res Methods doi: 10.3758/BF03193146 contributor: fullname: F Faul – volume: 21 start-page: 617 year: 2017 ident: 2089_CR30 publication-title: Korean J Physiol Pharmacol doi: 10.4196/kjpp.2017.21.6.617 contributor: fullname: KG Ulusoy – volume: 14 start-page: 170 year: 2022 ident: 2089_CR6 publication-title: Arch Cardiovasc Dis Suppl contributor: fullname: B Ballikaya – volume: 19 start-page: 615 year: 2000 ident: 2089_CR25 publication-title: Amino Acids doi: 10.1007/s007260070011 contributor: fullname: W Abebe – volume: 58 start-page: 551 year: 2019 ident: 2089_CR29 publication-title: Eur J Nutr doi: 10.1007/s00394-018-1616-2 contributor: fullname: VF Leão – volume: 46 start-page: 21 year: 2014 ident: 2089_CR10 publication-title: Amino Acids doi: 10.1007/s00726-012-1378-8 contributor: fullname: SW Schaffer – volume: 112 start-page: 443 year: 1994 ident: 2089_CR33 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1994.tb13092.x contributor: fullname: OL Woodman – volume: 12 start-page: 114 year: 2016 ident: 2089_CR34 publication-title: Med Chem doi: 10.2174/1573406411666150928112420 contributor: fullname: GC Bompotis – volume: 15 start-page: 5549 year: 2023 ident: 2089_CR9 publication-title: J Thorac Dis doi: 10.21037/jtd-23-636 contributor: fullname: J Lopez-Menendez – volume: 82 start-page: 279 year: 2008 ident: 2089_CR27 publication-title: Life Sci doi: 10.1016/j.lfs.2007.11.012 contributor: fullname: W Abebe – volume: 17 start-page: 155 year: 2020 ident: 2089_CR2 publication-title: Nat Rev Cardiol doi: 10.1038/s41569-019-0249-3 contributor: fullname: E Caliskan – volume: 136 start-page: 1636 year: 2006 ident: 2089_CR11 publication-title: J Nutr doi: 10.1093/jn/136.6.1636S contributor: fullname: JT Brosnan – volume: 56 start-page: 189 year: 2004 ident: 2089_CR16 publication-title: Exp Toxicol Pathol doi: 10.1016/j.etp.2004.08.004 contributor: fullname: J Hanna – volume: 84 start-page: 115 year: 2001 ident: 2089_CR24 publication-title: J Cell Biochem doi: 10.1002/jcb.1271 contributor: fullname: N Berna – volume: 81 start-page: 903 year: 2003 ident: 2089_CR26 publication-title: Can J Physiol Pharmacol doi: 10.1139/y03-088 contributor: fullname: W Abebe – volume: 54 start-page: 1527 year: 2022 ident: 2089_CR14 publication-title: Amino Acids doi: 10.1007/s00726-022-03198-6 contributor: fullname: O Yildiz – volume: 2001 start-page: 1004 issue: 91 year: 1985 ident: 2089_CR22 publication-title: J Appl Physiol contributor: fullname: TM Seasholtz – volume: 19 start-page: 1498 year: 2015 ident: 2089_CR13 publication-title: Eur Rev Med Pharmacol Sci contributor: fullname: K Karabacak – volume: 14 start-page: 1028 year: 2021 ident: 2089_CR5 publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph14101028 contributor: fullname: S Korkmaz-Icöz – volume: 68 start-page: 104 year: 1990 ident: 2089_CR32 publication-title: Can J Physiol Pharmacol doi: 10.1139/y90-016 contributor: fullname: C González – volume: 5 start-page: 245 year: 1991 ident: 2089_CR36 publication-title: Fundam Clin Pharmacol doi: 10.1111/j.1472-8206.1991.tb00716.x contributor: fullname: MT Ristori – volume: 45 start-page: 2425 year: 2014 ident: 2089_CR21 publication-title: Stroke doi: 10.1161/STROKEAHA.114.005888 contributor: fullname: MJ Cipolla – volume: 22 start-page: 461 year: 2008 ident: 2089_CR37 publication-title: Cardiovasc Drugs Ther doi: 10.1007/s10557-008-6124-9 contributor: fullname: W Xue – volume: 144 start-page: 728 year: 2021 ident: 2089_CR1 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.120.052163 contributor: fullname: I Xenogiannis – volume: 2022 start-page: 7019088 year: 2022 ident: 2089_CR8 publication-title: Stem Cells Int doi: 10.1155/2022/7019088 contributor: fullname: S Korkmaz-Icöz – volume: 26 start-page: 4913 year: 2021 ident: 2089_CR35 publication-title: Molecules doi: 10.3390/molecules26164913 contributor: fullname: CJ Jong – volume: 67 start-page: 541 year: 2016 ident: 2089_CR38 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.115.06624 contributor: fullname: Q Sun – volume: 393 start-page: 243 year: 2020 ident: 2089_CR19 publication-title: Naunyn Schmiedebergs Arch Pharmacol doi: 10.1007/s00210-019-01727-x contributor: fullname: BR Erdogan |
SSID | ssj0056815 |
Score | 2.3872724 |
Snippet | The primary objective of this study was to evaluate the protective effect of taurine on endothelial dysfunction in a vascular ischemia-reperfusion (IR) model.... The primary objective of this study was to evaluate the protective effect of taurine on endothelial dysfunction in a vascular ischemia-reperfusion (IR)... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
Title | Effect of taurine on vascular dysfunction in an in vitro ischemia-reperfusion model of rat thoracic aorta |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39349917 https://www.proquest.com/docview/3111637482 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9swDBbS9rLLsGGv7AUNWE-BBsUP2TpmeSyHoj0sBdKTocj05sPswkkKpNiPHyX51XUDusMAQzAEmzLIDxRJkTQhH8fBJsBLMp2a0E3IgUmugfE0jT0VitQHU--8_Bqdr-PZPJgPBj8br7-d-6-SxjmUtamc_Qdpt0RxAu9R5jii1HF8kNzrdsTm6N90DEIbEuXb5pumh63ZyZoMR2XHm3xXlaMc_Vz4kStWwTVU2d6E0dyPcgyxyhY9Il60afBqbPa-WVs3r-49Yarl7qa6bnsF2DaZGVFSujr3SZUfOpReVN9dVHZpfITRF3OW_3ladGnEM_xM_IDTaXgqF3VuWtZGwOGAPMJl3d5Rfctv-5ENL2jSMFplHAuficjVqn6C-3P31D-vy6HRzYqZpejxWDLZbXbNAf_5RbK4PDtLVvP16oiceKimUEueTNZXV7NmJze92UwKbLtmXXTlSi9_X-OuYfMXb8VaLasn5HHtbtCJw8lTMoDiGckdRmiZ0RojtCxoIyjawwjNC6rsaDFC_4QRajFiiCFGaIMAajHynFwu5qvpktW_3GAaXf0dk7EWGnW49KJAxeDpQHDw0k0URRlXAcQi0x4oobJUbMJMcr6JxmPN0aoNAELlvyDHRVnAK0JDCIVG2wdd5BSpqE2ciijToPFNjTSHZNTwK7l2nVWSroe24W6C3E0sdxM5JB8aliaoAM2pliqg3G8TH3drYZooeUPy0vG6pedLHz36cfT6AW-_IY86EL4lx7tqD-_I0Tbdv69x8QtYroR4 |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+taurine+on+vascular+dysfunction+in+an+in+vitro+ischemia-reperfusion+model+of+rat+thoracic+aorta&rft.jtitle=General+thoracic+and+cardiovascular+surgery&rft.au=Teimoori%2C+Ariyan&rft.au=Orhan%2C+Halit+G%C3%BCner&rft.au=Demirta%C5%9F%2C+Elif&rft.au=Zeynalova%2C+Nargiz&rft.date=2024-09-30&rft.issn=1863-6713&rft.eissn=1863-6713&rft_id=info:doi/10.1007%2Fs11748-024-02089-9&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1863-6705&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1863-6705&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1863-6705&client=summon |